|
||||
|
α-Synuclein & Parkinson’s Disease (PD) Parkinson’s disease (PD) is a neurodegenerative movement disorder that is characterized by the loss of dopaminergic neurons from the substantia nigra, and the formation of fibrillar intraneuronal inclusions (called Lewy bodies). Several lines of evidence point towards a central role for the process of α-synuclein fibrillization in the etiology of PD. First, α-synuclein is the primary component of Lewy bodies in all PD patients. Second, two different α-synuclein missense mutations (A30P and A53T) are associated with rare, autosomal dominant, early-onset PD and have been shown to form fibrils. Third, transgenic mice and Drosophila expressing human wild-type (WT) α-synuclein or, in the flies, the mutants, are characterized by α-synuclein inclusions that resemble Lewy bodies. In both models, the formation of these inclusions is correlated to the onset of disease phenotype. Finally, the PD-linked mutations (A30P and A53T), promote in vitro α-synuclein oligomerization, suggesting that the process of α-synuclein fibrillization may initiate neurodegeneration. α-synuclein amyloid fibril formation proceeds through a series of discrete oligomeric intermediates, referred to as protofibrils, that disappear upon fibril formation. Although both PD-linked mutations accelerate the formation of α-synuclein protofibrils, the A30P mutation was shown to delay the formation of amyloid fibrils relative to WT, suggesting that α-synuclein protofibrils, rather than fibrils, may be the pathogenic species. This hypothesis is supported by the observation that α-synuclein deposits in the brains of the “symptomatic” transgenic mice are non-fibrillar, and the fact that dopaminergic neurons that contain Lewy bodies appear to be healthier than neighboring neurons. Atomic force microscopy analysis of α-synuclein oligomerization demonstrated that α-synuclein protofibrils exist in spherical, chainlike and annular morphologies. In collaboration with Peter Lansbury (Brigham and Women’s Hospital), we investigated the effect of the familial PD mutations on the structural properties of α-synuclein protofibrils. By extending the biophysical studies to electron microscopy, analytical ultracentrifugation and scanning transmission electron microscopy, we showed that protofibrils of defined molecular size distribution and morphology are formed. In addition, we performed a detailed analysis of the morphological types of protofibrils using electron microscopy and single-particle averaging of negatively stained specimens.
|
||||